Friday 13 Jun, 2025 09:26 AM
Site map | Locate Us | Login
   Sasken Tech joins hands with Microsoft to drive next-gen smart devices innovation    SG Mart forays into renewable energy sector with launch of APL Apollo SunSteel    Maithan Alloys acquires minority stake in GAIL (India) for Rs 12 cr    Kay Cee Energy & Infra hits the roof on securing Rs 28 cr transmission order from RVPN    C.E. Info Systems Ltd leads losers in 'A' group    C E Info Systems slumps after block deal    Ashoka Buildcon tumbles as GST notice triggers search & seizure operation    Cinevista Ltd leads losers in 'B' group    Happiest Minds appoints Anand Balakrishnan as chief financial officer    Crisil Ratings reaffirms ratings of Ratnamani Metals at 'AA/A1+' with 'stable' outlook    Volumes spurt at RHI Magnesita India Ltd counter    NTPC's North Karanpura project completes trial operations of unit-3    Dr Reddys Laboratories Ltd up for third consecutive session    Ipca Laboratories Ltd soars 1.25%, Gains for third straight session    Oil & Natural Gas Corpn Ltd spurts 0.72%, rises for fifth straight session 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Alembic Pharma slips as USFDA issues four observations for Panelav API facility
02-Jun-25   11:58 Hrs IST

According to a regulatory filing, the USFDA conducted an unannounced and routine current good manufacturing practices (cGMP) inspection at the company's API-I and API-II facilities located at Panelav from 26 May 2025 to 31 May 2025.

The USFDA issued a form 483 with four observations and none of the observations are related to data integrity and management believes that they are addressable.

The company will provide comprehensive response to USFDA for the observations within the stipulated period.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. It manufactures and markets generic pharmaceutical products all over the world. Its research and manufacturing facilities are approved by regulatory authorities of many developed countries, including the USFDA.

The company's consolidated net profit declined 12% to Rs 156.89 crore despite a 16.7% jump in net sales to Rs 1,769.64 crore in Q4 FY25 over Q4 FY24.

Powered by Capital Market - Live News
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Account Closure | RE-KYC | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures | Rights & Obligations-English | (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language | Anti Money Laundering Policy | E-Voting | CSR | Voluntary Freezing / Blocking | Policy GTC | Policy On Inactive Trading Accounts | Risk Disclosure Hit Count : 41900356
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited